Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

Abroad (travel likely)RecruitingPHASE1

Conditions

Cardiomyopathy · Heart Failure · Hematopoietic and Lymphoid Cell Neoplasm · Malignant Solid Neoplasm

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

M D Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Amanda Olson, MD) · alolson@mdanderson.org · 713-745-3055
Contact: Principal Investigator (Amanda Olson, MD)

Study leads

Amanda Olson, MD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades

Pacing-Induced Cardiomyopathy · Heart Failure

Abroad (travel likely)Recruiting

Cambridge, United Kingdom · Chichester, United Kingdom

The Role of CD34+ Stem Cells in the Pathogenesis of Takotsubo Syndrome

Tako Tsubo Cardiomyopathy · Microvascular Dysfunction · CD34+ Stem Cells

Abroad (travel likely)Recruiting

Ljubljana, Slovenia

Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy

Left Bundle-Branch Block · Heart Failure · Cardiac Resynchronization Therapy

Abroad (travel likely)Recruiting

Aalborg, Denmark

Implantable Cardioverter Defibrillator (ICD Registry)

Heart Failure · Nonischemic Cardiomyopathy · Ischemic Cardiomyopathy

Abroad (travel likely)Recruiting

Washington D.C., United States